Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 5/20 | 0.50 |
| ▸ | WDR77 | Q9BQA1 | 5/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.49 |
| ▸ | AHCY | P23526 | 3/20 | 0.47 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.47 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10365540 | 0.88 | PRMT5 (0.58) | PRMT5WDR77ADORA3AHCYADORA2B | |
| SCHEMBL17460352 | 0.87 | PRMT5 (0.54) | PRMT5WDR77ADORA3AHCYADORA2B | |
| SCHEMBL101381 | 0.86 | AHCY (0.63) | PRMT5WDR77ADORA3AHCYADORA2B | |
| SCHEMBL29352139 | 0.86 | AHCY (0.63) | PRMT5WDR77ADORA3AHCYADORA2B | |
| SCHEMBL28672423 | 0.85 | PRMT5 (0.53) | PRMT5WDR77ADORA3AHCYADORA2B | |
| SCHEMBL6538405 | 0.85 | PRMT5 (0.53) | PRMT5WDR77ADORA3AHCYADORA2B | |
| SCHEMBL3515650 | 0.84 | PRMT5 (0.50) | PRMT5WDR77ADORA3AHCYADORA2B | |
| SCHEMBL9052971 | 0.83 | AHCY (0.49) | PRMT5WDR77ADORA3AHCYADORA2B | |
| SCHEMBL11681025 | 0.83 | PRMT5 (0.51) | PRMT5WDR77ADORA3AHCYADORA2B | |
| SCHEMBL4308125 | 0.82 | DNPH1 (0.48) | PRMT5WDR77AHCY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9290501-B2 | Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) | 2016-03-22 | — | — | US | claimed |
| US-20130274220-A1 | METHODS, ASSAYS AND COMPOUNDS FOR TREATING BACTERIAL INFECTIONS BY INHIBITING METHYLTHIOINOSINE PHOSPHORYLASE | INDUSTRIAL RESEARCH LIMITED (NZ) | 2013-10-17 | — | — | US | claimed |
| WO-2012074912-A1 | METHODS, ASSAYS AND COMPOUNDS FOR TREATING BACTERIAL INFECTIONS BY INHIBITING METHYLTHIOINOSINE PHOSPHORYLASE | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2012-06-07 | — | — | WO | claimed |
| US-9522159-B2 | Treatment and prevention of P. aeruginosa infections using coformycin analogs | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) | 2016-12-20 | — | — | US | disclosed |
| US-9290501-B2 | Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) | 2016-03-22 | — | — | US | disclosed |
| US-20150231165-A1 | TREATMENT AND PREVENTION OF P. AERUGINOSA INFECTIONS USING COFORMYCIN ANALOGS | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2015-08-20 | — | — | US | disclosed |
| WO-2014043046-A1 | TREATMENT AND PREVENTION OF P. AERUGINOSA INFECTIONS USING COFORMYCIN ANALOGS | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2014-03-20 | — | — | WO | disclosed |
| US-20130274220-A1 | METHODS, ASSAYS AND COMPOUNDS FOR TREATING BACTERIAL INFECTIONS BY INHIBITING METHYLTHIOINOSINE PHOSPHORYLASE | INDUSTRIAL RESEARCH LIMITED (NZ) | 2013-10-17 | — | — | US | disclosed |
| US-8394950-B2 | Analogues of coformycin and their use for treating protozoan parasite infections | INDUSTRIAL RESEARCH LIMITED (NZ) | 2013-03-12 | — | — | US | disclosed |
| WO-2012074912-A1 | METHODS, ASSAYS AND COMPOUNDS FOR TREATING BACTERIAL INFECTIONS BY INHIBITING METHYLTHIOINOSINE PHOSPHORYLASE | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2012-06-07 | — | — | WO | disclosed |
| US-20100330126-A1 | Attenuated malaria blood-stage vaccine | NATIONAL INSTITUTES OF HEALTH | 2010-12-30 | — | — | US | disclosed |
| US-20090227532-A1 | Analogues of Coformycin and Their Use for Treating Protozoan Parasite Infections | ALBERT EINSTEIN COLLEGE OF MEDICINE | 2009-09-10 | — | — | US | disclosed |
| WO-2007097643-A1 | ANALOGUES OF COFORMYCIN AND THEIR USE FOR TREATING PROTOZOAN PARASITE INFECTIONS | INDUSTRIAL RESEARCH LIMITED (NZ) | 2007-08-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227532-A1 | Analogues of Coformycin and Their Use for Treating Protozoan Parasite Infections | PDF, PPIF, MT-CO1 | PRMT5 3846/4885WDR77 1179/4885ADORA3 3391/4885 |
| US-20150231165-A1 | TREATMENT AND PREVENTION OF P. AERUGINOSA INFECTIONS USING COFORMYCIN ANALOGS | MTAP, DCTD, ADA | PRMT5 1092/4885WDR77 1740/4885ADORA3 481/4885 |
| US-20130274220-A1 | METHODS, ASSAYS AND COMPOUNDS FOR TREATING BACTERIAL INFECTIONS BY INHIBITING METHYLTHIOINOSINE PHOSPHORYLASE | MTAP, MPG, MTMR1 | PRMT5 349/4885WDR77 2407/4885ADORA3 2425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.